Difficulty: Medium
Average Score: 73%
Practice
A 40-year-old patient experiencing periods of mania and periods of depression would most likely benefit from which of the following?
Correct answer
D
Rationale
In the case of a 40-year-old patient experiencing periods of mania and depression, the most suitable medication would be Carbamazepine (Tegretol). Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used in the treatment of bipolar disorder. It helps to control manic episodes and stabilize mood swings in patients with bipolar disorder.
A) Atomoxetine (Strattera) is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) and would not be the first-line choice for a patient presenting with manic and depressive episodes.
B) Amitriptyline (Elavil) is a tricyclic antidepressant used to treat depression and anxiety disorders. It is not the preferred medication for managing bipolar disorder.
C) Methylphenidate (Ritalin) is a stimulant medication used to treat ADHD and narcolepsy. It is not indicated for the treatment of bipolar disorder.
Educationally, it is crucial for healthcare providers to understand the mechanism of action and specific indications of different pharmacological agents to make informed decisions in patient care. In the context of advanced pharmacology across the lifespan, knowing the appropriate use of mood-stabilizing agents like Carbamazepine in managing bipolar disorder is essential for providing effective treatment and improving patient outcomes.
A) Atomoxetine (Strattera) is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) and would not be the first-line choice for a patient presenting with manic and depressive episodes.
B) Amitriptyline (Elavil) is a tricyclic antidepressant used to treat depression and anxiety disorders. It is not the preferred medication for managing bipolar disorder.
C) Methylphenidate (Ritalin) is a stimulant medication used to treat ADHD and narcolepsy. It is not indicated for the treatment of bipolar disorder.
Educationally, it is crucial for healthcare providers to understand the mechanism of action and specific indications of different pharmacological agents to make informed decisions in patient care. In the context of advanced pharmacology across the lifespan, knowing the appropriate use of mood-stabilizing agents like Carbamazepine in managing bipolar disorder is essential for providing effective treatment and improving patient outcomes.